Rachel Chase MD in Louisville, Kentucky

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Kentucky College Of Medicine
Graduation Year: 2003
The Primary Medical Specialty for Rachel Chase MD is listed as: Rheumatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 21
PAC (PECOS ID)#: 9537263736
NPI #: 1518052893
NPI Created On: 10/04/2006
NPI Last Updated Listed as: 09/28/2021
Primary Taxonomy Code: 207RR0500X
License Number:
40356
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Insertion of needle into vein for collection of blood sample
3. Bone density measurement using dedicated x-ray machine
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Infusion of chemotherapy into a vein up to 1 hour
8. Infusion of chemotherapy into a vein
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Physician telephone patient service, 11-20 minutes of medical discussion
13. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
14. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
15. Injection, denosumab, 1 mg
16. Injection, diphenhydramine hcl, up to 50 mg
17. Injection, golimumab, 1 mg, for intravenous use
18. Injection, hydrocortisone sodium succinate, up to 100 mg
19. Injection, infliximab, excludes biosimilar, 10 mg
20. Injection, methylprednisolone sodium succinate, up to 40 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).